These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22049481)

  • 21. Screening for ADHD in an adult social phobia sample.
    Mörtberg E; Tilfors K; Bejerot S
    J Atten Disord; 2012 Nov; 16(8):645-9. PubMed ID: 22100689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
    Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
    Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales.
    Murphy KR; Adler LA
    J Clin Psychiatry; 2004; 65 Suppl 3():12-7. PubMed ID: 15046530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trait aggression, depression and suicidal behavior in drug dependent patients with and without ADHD symptoms.
    Bácskai E; Czobor P; Gerevich J
    Psychiatry Res; 2012 Dec; 200(2-3):719-23. PubMed ID: 22749152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
    Coetzee C; Truter I; Meyer A
    Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1271-1280. PubMed ID: 33040639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.
    Young JT; Carruthers S; Kaye S; Allsop S; Gilsenan J; Degenhardt L; van de Glind G; van den Brink W; Preen D
    Drug Alcohol Rev; 2015 Nov; 34(6):683-93. PubMed ID: 25790353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of the Japanese version of the Adult Attention-deficit hyperactivity disorder (ADHD) Self-Report Scale (ASRS-J) and its short scale in accordance with DSM-5 diagnostic criteria.
    Takeda T; Tsuji Y; Kurita H
    Res Dev Disabil; 2017 Apr; 63():59-66. PubMed ID: 28260624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability The use of Conners' Adult ADHD Rating Scales (CAARS).
    La Malfa G; Lassi S; Bertelli M; Pallanti S; Albertini G
    Res Dev Disabil; 2008; 29(2):158-64. PubMed ID: 17416484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing ADHD in Israeli adults: the psychometric properties of the adult ADHD Self Report Scale (ASRS) in Hebrew.
    Zohar AH; Konfortes H
    Isr J Psychiatry Relat Sci; 2010; 47(4):308-15. PubMed ID: 21270505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the reliability and preliminary validity of the Adult ADHD Self-Report Scale v1.1 (ASRS v1.1) Screener in an adolescent community sample.
    Green JG; DeYoung G; Wogan ME; Wolf EJ; Lane KL; Adler LA
    Int J Methods Psychiatr Res; 2019 Mar; 28(1):e1751. PubMed ID: 30407687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing US norms for the Adult ADHD Self-Report Scale (ASRS-v1.1) and characterising symptom burden among adults with self-reported ADHD.
    Adler LA; Faraone SV; Sarocco P; Atkins N; Khachatryan A
    Int J Clin Pract; 2019 Jan; 73(1):e13260. PubMed ID: 30239073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation and bifactor structure of the French Adult ADHD Symptoms Rating Scale v1.1 (ASRS).
    Caci H; Didier C; Wynchank D
    Encephale; 2024 Feb; 50(1):68-74. PubMed ID: 36641267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications.
    van der Burg D; Crunelle CL; Matthys F; van den Brink W
    Curr Opin Psychiatry; 2019 Jul; 32(4):300-306. PubMed ID: 31008730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and correlates of attention deficit hyperactivity disorder in adults from a French community sample.
    Caci HM; Morin AJ; Tran A
    J Nerv Ment Dis; 2014 Apr; 202(4):324-32. PubMed ID: 24647218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample.
    Snyder SM; Quintana H; Sexson SB; Knott P; Haque AF; Reynolds DA
    Psychiatry Res; 2008 Jun; 159(3):346-58. PubMed ID: 18423617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Validation in the adult Spanish population of the Wender Utah Rating Scale for the retrospective evaluation in adults of attention deficit/hyperactivity disorder in childhood].
    Rodríguez-Jiménez R; Ponce G; Monasor R; Jiménez-Giménez M; Pérez-Rojo JA; Rubio G; Jiménez Arriero ; Palomo T
    Rev Neurol; 2001 Jul 16-31; 33(2):138-44. PubMed ID: 11562873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Utility of the Wender-Utah rating scale and the checklists for the diagnosis of familial attention deficit hyperactivity disorder in adults. Convergent and concurrent validities].
    Pineda DA; Trujillo-Orrego N; Aguirre-Acevedo DC; Arango CP; Hincapié-Henao L; Montoya-Arenas DA; Lopera F; Pineda-Alvarez DE; Arcos-Burgos M; Muenke M
    Rev Neurol; 2010 Feb 16-28; 50(4):207-16. PubMed ID: 20198592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.